Provectus Biopharmaceuticals PVCT
OTC PVCT
$0.05 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Provectus Biopharmaceuticals (PVCT) Capital Expenditures (2012 - 2017)

Updated

Provectus Biopharmaceuticals (PVCT) reported Capital Expenditures of $4,761 for Q4 2017.

Analysis

Provectus Biopharmaceuticals (PVCT) Capital Expenditures (2012 - 2017) Analysis & Trends

For FY2017, Provectus Biopharmaceuticals posted Capital Expenditures of $30,400.

  • Capital Expenditures has a five-year compound annual growth rate of 13.9% (FY2012 to FY2017).
  • By year, Capital Expenditures came in at $6,139 in FY2015 (-91.3%), $70,590 in FY2014 (+961.5%) and $6,650 in FY2013 (-58.1%).
  • The Q4 2017 figure ranks as the highest quarterly Capital Expenditures since Q1 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 1.36 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 322.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 1.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 140.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 533.00 Mn
10 Provectus Biopharmaceuticals 21.01 Mn 19.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 4,761.00
Mar 31, 2012 15,885.00
API Access

Provectus Biopharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PVCT&period=max&api_key=YOUR_API_KEY